Opportunity

Simpler Grants.gov #PA-25-253

NIH R21 Grants for Exploratory Cancer Control Research

Buyer

National Institutes of Health

Posted

November 12, 2024

Respond By

September 07, 2028

Identifier

PA-25-253

NAICS

541715, 541714, 541720

The National Institutes of Health (NIH) is seeking applications for exploratory and developmental research grants (R21) in cancer control research. - Government Buyer: - National Institutes of Health (NIH) - Scope of Opportunity: - Supports early-stage research on novel scientific ideas in cancer control - Focus areas include epidemiologic, biomedical, behavioral, health care delivery, and clinical research - Encourages development of new techniques, agents, methodologies, models, or applications relevant to cancer research - Products/Services Requested: - No specific products or OEMs are requested; this is a grant for research activities - Service: Exploratory/Developmental Cancer Control Research Grant (R21) - Supports innovative research projects with potential to advance population-based cancer research - Eligibility: - Open to government entities, nonprofits, businesses, educational institutions, and other organizations - Notable Requirements: - Emphasis on early-stage, high-impact research ideas - Opportunity listed under Assistance Listings 93.393 and 93.399 (Cancer Cause and Prevention/Control Research)

Description

This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications focusing on various aspects of cancer control, including behavior modification, screening, and understanding etiologic factors contributing to cancer development. The goal is to support early-stage research efforts on novel scientific ideas that could substantially advance population-based cancer research. This includes the development of new techniques, agents, methodologies, models, or applications with potential major impact in cancer research fields such as epidemiologic, biomedical, behavioral, health care delivery, or clinical research.

View original listing